Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Peter Molloy has a successful track record of profitably recycling old drugs


Byotrol Share Price (BYOT)



Share Price Information for Byotrol (BYOT)


Share Price: 3.25Bid: 3.00Ask: 3.50Change: 0.00 (0.00%)No Movement on Byotrol
Spread: 0.50Spread as %: 16.67%Open: 3.375High: 3.375Low: 3.125Yesterday’s Close: 3.25

Byotrol Plc Ords 0.25P

Byotrol is listed in the FTSE AIM All-Share
Byotrol is part of the Industrial Chemicals sector






Share Price SpacerPrice
3.25

Share Price SpacerBid
3.00

Share Price SpacerAsk
3.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
785,000

Share Price SpacerOpen
3.375

Share Price SpacerHigh
3.375

Share Price SpacerLow
3.125

Share Price SpacerClose
3.25

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 402.84m £13.09m 7,500

52 Week High 5.88 52 Week High Date 13-JUN-2017
52 Week Low 3.13 52 Week Low Date 23-NOV-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
6 0 785,000 -65.000 -0.05 0.00 0.00


London South East Users info for Byotrol




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

23-Nov-17
15:54:25
3.25
500,000
 
3.00
3.50
16.25k
Trade Type:
Ordinary
Delayed publication

23-Nov-17
15:58:32
3.25
150,000
Buy* 
3.00
3.25
4,875
Trade Type:
Ordinary
Delayed publication

23-Nov-17
15:55:57
3.25
250,000
Buy* 
3.00
3.25
8,125
Trade Type:
Ordinary
Delayed publication




View more Byotrol trades >>

Directors Deals for Byotrol (BYOT)
Trade DateActionNotifierPriceCurrencyAmountHolding
04-Sep-17Notification of Holding
Trade Notifier Information for Byotrol
Till Medinger held the position of Non-Executive Director at Byotrol at the time of this trade.
 Till Medinger
002307224
04-Sep-17Notification of Holding
Trade Notifier Information for Byotrol
Trevor Francis held the position of Chief Technology Officer at Byotrol at the time of this trade.
 Trevor Francis
002253216
04-Sep-17Notification of Holding
Trade Notifier Information for Byotrol
John T Langlands held the position of Chairman at Byotrol at the time of this trade.
 John T Langlands
004100000
View more Byotrol directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Wed 20:35ShroderRE: "No and no again"3.375No Opinion
Maybe the tail end of a fund, no idea but the recent placing was oversubscribed hence my earlier comment about holders not selling.

I fully understand any negative sentiment and as mentioned earlier tend to agree somewhat, that said the share register along with the company has evolved, new funds are on-board, Amati in particular are small cap specialists.

http://www.amatiglobal.com/
Wed 17:56lukehere"No and no again"3.375No Opinion
One couldn't be too sure about that Shroder as, in view of today's 1,000,000 sale @ 3.25 pence,the portents remain unsettling.
Tue 13:42IdeasByScienceRE: Solvay3.50No Opinion
You have seen this cycle once, like many firsts delivered by this business. A recent addition being: £how to take the great idea, turn it into dog shampoo and laud this as innovation£.
12 Nov '17ShroderByotrol looking to expand pet care3.625No Opinion
9 Nov '17ShroderRE: Share price retreat3.625No Opinion
luke in answer to your first two questions, no and no again.

I would agree with you if it were not a completely different company, this includes all the products and staff (bar one I think)

The BOD are well respected which has attracted new investment and funds keen to see Byotrol progress, the fund raising was also oversubscribed so no shortage of investors (some were pared back).

The heavy lifting is done, reformulations, FDA,EPA approvals are all in place, the job in hand is now to… Read More
9 Nov '17lukehereShare price retreat3.375Strong Sell
Are holders heading for the exit door ?
Is Byotrol looking at delisting ?
Why should revenues do anything but fall now that future Solvay payments seem to be off the table.
A look at the adverse P&L account ,built up over too many years, tells you all that you need to know about Byotrol's lack of success in commercialising their "technology".

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Byotrol (BYOT) >>

Please login or register to post a message on Share Chat.





Byotrol Plc Ords 0.25P home pageWebsite: Byotrol Plc Ords 0.25P
Website Description: Byotrol - The Hygiene Revolution



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.